Coty expands celeb offering
This article was originally published in The Rose Sheet
Executive Summary
Coty is partnering with singer Gwen Stefani to develop and market a line of fragrances under her L.A.M.B. brand, company announces Dec. 6. The yet-to-be-named fragrance, designed to channel the "blend of verve, style and vivacity" of L.A.M.B., will debut in fall 2007, Coty says. Stefani introduced the fashion brand in 2003; this is her first foray into the fragrance market. Coty expects Stefani's "distinctive look, music and embrace of ethnic influences" to drive the fragrance's appeal. "This will be no ordinary perfume. From the packaging to the bottle design to the distinctive scent itself, we will be working very closely with Gwen to ensure that her signature fragrance captures her rare spirit, style and warmth," Coty says. The firm's numerous celebrity partners include David Beckham and Jennifer Lopez...
You may also be interested in...
New Scents May Have Consumers Spending More Than Planned This Holiday
Consumers purportedly intend to spend less on fragrances this holiday season, according to a survey released by the NPD Group Oct. 9; however, senior beauty analyst Karen Grant suspects that actual purchasing behavior may belie initial plans
As Casgevy, Lyfgenia Launches Proceed, CRISPR And bluebird bio CEOs Reassure
The CEOs of bluebird bio and CRISPR Therapeutics hope to inspire investor confidence that their gene-based therapies for sickle cell disease and beta thalassemia will be widely reimbursed in the US and EU.
Japan Regulatory Update: Revised Law Widens RWD Scope, Price Revisions/Listings
Japan now allows pseudonymized personal data for medical use under a licensing system for wider use of real-world data. Meanwhile, a national cost-effectiveness assessment scheme has slashed reimbursement prices for Lagevrio and Kerendia, and Alexion’s Voydeya has been added to the reimbursement tariff.